Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

6.7K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.7K
Imaging Studies IV: Magnetic Resonance Imaging01:27

Imaging Studies IV: Magnetic Resonance Imaging

178
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
178
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

391
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
391
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

8.8K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
8.8K
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

246
Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
246

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical PET/MR.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2026
Same author

Prognostic Value of [<sup>18</sup>F]Flotufolastat PET Using Visual RECIP in Docetaxel-Treated Metastatic Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Baby Boomers in Germany: a secondary data analysis of demographics, regional disparities, healthcare utilization, and mortality.

BMC public health·2026
Same author

Caesarean section Robson classification, complications, and lessons learned in a rural hospital in Walikale, North Kivu, Democratic Republic of Congo: a cross-sectional study.

AJOG global reports·2026
Same author

Digital Twins for Radiopharmaceutical Dosimetry: PBPK Modelling of [<sup>177</sup>Lu]Lu-rhPSMA-10.1 in a Preclinical mCRPC Model.

Cancers·2025
Same author

MgO Tunneling Spintronics across Capacitively Coupled Atomic Clusters.

Nano letters·2025

Related Experiment Video

Updated: Dec 17, 2025

MRI and PET in Mouse Models of Myocardial Infarction
10:46

MRI and PET in Mouse Models of Myocardial Infarction

Published on: December 19, 2013

12.2K

Clinical PET/MR.

Wolfgang Weber1

  • 1Department of Nuclear Medicine, School of Medicine, Technical University Munich, Ismaningerstr 22, 81675, Munich, Germany. w.weber@tum.de.

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|June 29, 2020
PubMed
Summary
This summary is machine-generated.

Positron emission tomography/magnetic resonance imaging (PET/MR) offers lower radiation doses for oncologic imaging, especially for children. However, longer scan times and higher costs limit its widespread use, making it more suitable for specific cancer staging.

Keywords:
FDGFluorodeoxyglucoseMR/PETMultimodal imagingPET/MRPET/MRIPSMAProstate-specific membrane antigen

More Related Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.4K
Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT
10:53

Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT

Published on: November 23, 2012

19.6K

Related Experiment Videos

Last Updated: Dec 17, 2025

MRI and PET in Mouse Models of Myocardial Infarction
10:46

MRI and PET in Mouse Models of Myocardial Infarction

Published on: December 19, 2013

12.2K
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

11.4K
Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT
10:53

Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT

Published on: November 23, 2012

19.6K

Area of Science:

  • Oncology
  • Medical Imaging
  • Radiology

Background:

  • PET/MR imaging has been extensively researched for oncologic applications over the past decade.
  • FDG PET/MR demonstrates comparable accuracy to FDG PET/CT for tumor staging.
  • FDG PET/MR offers a significant reduction in radiation exposure compared to FDG PET/CT, benefiting pediatric patients.

Purpose of the Study:

  • To evaluate the current role and future potential of PET/MR in oncologic imaging.
  • To compare the diagnostic performance and limitations of PET/MR with PET/CT.
  • To identify specific clinical scenarios where PET/MR offers advantages.

Main Methods:

  • Review of existing clinical research on PET/MR in oncology.
  • Comparison of accuracy, radiation dose, acquisition time, and cost between PET/MR and PET/CT.
  • Analysis of PET/MR utility in specific cancer types, including brain tumors, head and neck cancers, gynecologic malignancies, and prostate cancer.

Main Results:

  • PET/MR shows similar tumor staging accuracy to PET/CT but with over 50% lower radiation dose.
  • Longer acquisition times and higher costs currently limit whole-body PET/MR staging.
  • PET/MR is more promising for locoregional staging in cancers where MR is the preferred anatomical imaging modality.

Conclusions:

  • PET/MR is particularly advantageous for pediatric oncology due to reduced radiation.
  • Its current limitations restrict broad clinical adoption for whole-body staging.
  • PET/MR shows significant promise for locoregional staging of specific cancers like prostate cancer, especially when combined with multi-parametric MR techniques.